Market revenue in 2021 | USD 14.0 million |
Market revenue in 2030 | USD 84.4 million |
Growth rate | 22.1% (CAGR from 2021 to 2030) |
Largest segment | Oncology |
Fastest growing segment | CVD |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
Key market players worldwide | The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 22.86% in 2021. Horizon Databook has segmented the Saudi Arabia ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
The macroeconomic stability provided by Saudi Arabia is one of the significant factors expected to boost the penetration of pharmaceutical companies for conducting clinical trials in the country. This would help in increasing adoption of AI-based solutions for better clinical research management and results.
Owing to these factors, Saudi Arabia is one of the most lucrative countries in the Middle East for clinical trials. It has the one of largest number of hospitals and primary health centers in the region. With higher number of nurses, physicians and healthcare staff, the country stands among the leading countries in the region in terms of health resources.
Moreover, major upcoming projects aim at developing hospitals, such as King Khalid Medical City, King Faisal Medical City, and King Abdullah Medical City, which is expected to increase research facilities. This is expected to create growth opportunities for market players in Saudi Arabia.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia ai-based clinical trials solution provider market, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account